【2月12日IPO雷达】海圣医疗上市

Group 1 - The core business of the company focuses on anesthesia and monitoring medical devices, catering to clinical needs in ICU and emergency departments [2] - The company has established a product matrix for anesthesia, monitoring, surgical, and nursing products, mastering 14 core technologies that support its product offerings [2] - The company's main products are widely used in thousands of tertiary hospitals across the country [2] Group 2 - The issuance price of the company's shares is set at 12.64 yuan [2] - The issuance price-to-earnings ratio is 13.99, indicating the valuation of the company in the industry [2] - The subscription rate for the shares is 0.02%, reflecting investor interest in the offering [2]